THRSP and hepatocellular carcinoma: These results suggest that THRSP may mediate T3-induced HCC inhibition and ENO2 downregulation by activating Raptor phosphorylation via the LKB1/AMPK pathway, which in turn suppresses mTOR activity and HIF-1α nuclear translocation in HCC.